Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9327185 | 0.93 | HTT (0.36) | MAPTHTTSMN1; SMN2HSD17B10POLB | |
| SCHEMBL14003053 | 0.93 | HTT (0.36) | MAPTHTTSMN1; SMN2HSD17B10POLB | |
| SCHEMBL9773244 | 0.81 | MAPT (0.40) | MAPT | |
| SCHEMBL9773214 | 0.81 | MAPT (0.40) | MAPT | |
| SCHEMBL9773246 | 0.81 | MAPT (0.40) | MAPT | |
| SCHEMBL9702539 | 0.81 | MAPT (0.40) | MAPT | |
| SCHEMBL29308571 | 0.80 | CA1 (0.40) | MAPTHTTSMN1; SMN2HSD17B10 | |
| SCHEMBL29308554 | 0.80 | CA1 (0.40) | MAPTHTTSMN1; SMN2HSD17B10 | |
| SCHEMBL10088095 | 0.80 | CA1 (0.40) | MAPTHTTSMN1; SMN2HSD17B10 | |
| SCHEMBL2326461 | 0.80 | HSD17B10 (0.35) | MAPTHTTSMN1; SMN2HSD17B10POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4583926-A1 | CONTRAST AGENTS FOR USE IN DIAGNOSTIC COMPUTED TOMOGRAPHY IMAGING | Bayer Aktiengesellschaft (DE) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024052550-A1 | CONTRAST AGENTS FOR USE IN DIAGNOSTIC COMPUTED TOMOGRAPHY IMAGING | BAYER AKTIENGESELLSCHAFT (DE) | 2024-03-14 | — | — | WO | disclosed |
| EP-4308551-A1 | NEW CONTRAST AGENT FOR USE IN MAGNETIC RESONANCE IMAGING | Bayer Aktiengesellschaft (DE) | 2024-01-24 | — | — | EP | disclosed |
| WO-2022194777-A1 | NEW CONTRAST AGENT FOR USE IN MAGNETIC RESONANCE IMAGING | BAYER AKTIENGESELLSCHAFT (DE) | 2022-09-22 | — | — | WO | disclosed |